
|Articles|April 3, 2006
Latebreakers: April 3, 2006
President Bush nominated acting FDA commissioner Andrew vonEschenbach, M.D., to permanently head the agency. Eschenbach, whoalso heads the National Cancer Institute, may faceconflict-of-interest charges at his confirmation hearings, andSenate Democrats have threatened to hold up his confirmation overFDA's inaction on OTC status for the emergency contraceptive PlanB. NCPA and NACDS had no comment on the Eschenbach nomination, butAPhA views him as an "excellent choice."
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Accepts Sandoz Applications for Generic Tirzepatide
2
Making Medication Management Services Measurable and Visible
3
Amazon, Fleming Initiative Partner to Combat Antimicrobial Resistance
4
Tech-Driven Home Pharmacy Model Tackles Rural Health Crises
5































